Tagged 'Recall'

Drugs
NDMA, Cancer and Medical Drugs
NDMA (n-nitrosodimethylamine) is the probable human carcinogen behind a number of recent drug recalls. As of July 2020, NDMA has been found in blood […]
July 30, 2020
Author Katy Moncivais, Ph.D.
Read More
Safety
Current Status of the Zantac Recall
Zantac is a brand name heartburn medication previously available in over-the-counter (OTC) and prescription forms. Before the recall, Zantac was commonly sold as generic […]
July 28, 2020
Author Katy Moncivais, Ph.D.
Read More
Drugs
The FDA Requests Market Withdrawal of All Zantac Products
Roughly six months ago, drug manufacturers began recalling Zantac (ranitidine) heartburn medications. This month, the U.S. Food and Drug Administration (FDA) requested all Zantac […]
April 16, 2020
Author Katy Moncivais, Ph.D.
Read More
Drugs
Zantac MDL Adds to Manufacturers' Troubles
Recently, contamination triggered widespread recalls of Zantac heartburn medication. As a result, the drug's manufacturers now face a growing number of legal and financial […]
February 21, 2020
Author Katy Moncivais, Ph.D.
Read More
Safety
Top Three Things to Know About the 2019 Johnson’s Baby Powder Recall
Top Three Things to Know About the 2019 Johnson's Baby Powder Recall 1: The Recalled, Asbestos-Contaminated Baby Powder May Not Have Been Authentic 2: […]
December 11, 2019
Author Katy Moncivais, Ph.D.
Read More
Legal
Legal Look: JUUL Problems, Asbestos in Baby Powder, Roundup Lawsuits
This week's Legal Look covers new legal troubles for JUUL, a baby product contaminated with asbestos, and thousands of new Roundup lawsuits. Former JUUL […]
November 1, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Losartan vs Valsartan
The generic versions of losartan and valsartan made national headlines this past year when the FDA announced a significant number of recalls after finding […]
August 23, 2019
Author Katy Moncivais, Ph.D.
Read More
Medical Devices
FDA Links Breast Implants to Cancer, Allergan Issues Global Recall
Top Three Messages for Breast Implant Recipients Specific models of Allergan breast implants are associated with 6x greater risk of breast implant-associated anaplastic large […]
July 26, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Fourth Probable Carcinogen Found in Valsartan Medication
Last week brought a shocking new discovery to the year-long saga of generic blood pressure medication recalls. The online pharmaceutical retailer Valisure reportedly found […]
June 21, 2019
Author Katy Moncivais, Ph.D.
Read More
Legal
Legal Look: Monsanto Mediation, TVM Takedown and Talc Transfers
In this issue of the Legal Look we are examining a judge's order for Monsanto to mediate the latest Roundup lawsuit, the FDA's recent […]
April 25, 2019
Author Curtis Weyant
Read More
Drugs
Sartan Blood Pressure Drug Lawsuits Gaining Traction
Valsartan is not the only sartan-based blood pressure medication to raise concerns in recent months. Since the U.S. Food and Drug Administration (FDA) started […]
March 5, 2019
Author Katy Moncivais, Ph.D.
Read More
Drugs
Legal Look: Valsartan Recalls, Prostate Cancer Misdiagnosis, J&J Talc Asbestos Lawsuits and Roundup Class Actions
In this issue of the Legal Look, we are covering a would-be Roundup class action lawsuit in Wisconsin that was denied certification, the expansion […]
January 16, 2019
Author Curtis Weyant
Read More